Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer

Breast cancer has historically been a disease for which immunotherapy was largely unavailable. Recently, the use of immune checkpoint inhibitors (ICIs) in combination with chemotherapy for the treatment of advanced/metastatic triple-negative breast cancer (TNBC) has demonstrated efficacy, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Emens, Leisha A, Adams, Sylvia, Cimino-Mathews, Ashley, Disis, Mary L, Gatti-Mays, Margaret E, Ho, Alice Y, Kalinsky, Kevin, McArthur, Heather L, Mittendorf, Elizabeth A, Nanda, Rita, Page, David B, Rugo, Hope S, Rubin, Krista M, Soliman, Hatem, Spears, Patricia A, Tolaney, Sara M, Litton, Jennifer K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365813/
https://www.ncbi.nlm.nih.gov/pubmed/34389617
http://dx.doi.org/10.1136/jitc-2021-002597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365813/
https://www.ncbi.nlm.nih.gov/pubmed/34389617
http://dx.doi.org/10.1136/jitc-2021-002597

Ejemplares similares